Daily ASX Market Close: BHP Anglo American proposal update - May 29, 2024

The ASX200 didn’t seem to be able to recover from the CPI inflation data April read – showing a rise to 3.6 per cent – which was hotter than many had forecast. The index lost more than 1.15 per cent – all sectors were down with Consumer Staples, Industrials and Financials suffering the most.

Market Update: Unexpected CPI data rattles and shakes ASX

Australia's CPI inflation indicator increased 3.6% in April on a year-on-year basis, up from 3.5% in March, causing an instant sell off on the ASX200.

Ark Mines up 8% as maiden rare earth JORC for Sandy Mitchell hits the bourse

Ark Mines (ASX:AHK) has been spared the battering of a red day on delivery of its maiden resource for rare earths (REEs) at Sandy Mitchell.

De Grey raises $600M to progress work at WA's Hemi Gold Project

De Grey Mining Ltd has raised a total of $600 million to fund work at its Hemi Gold Project in Western Australia.

ASX200 sells off as CPI inflation hotter than expected at 3.6%. Are we over-reacting?

Australia's CPI inflation indicator increased in April by 3.6% on a YoY basis, causing an instant sell off on the ASX200.

Oar Minerals see shares rise 33% on news of massive Brazilian land increase

Oar Resources Ltd has increased its landholding in Brazil by 283%, picking up two additional uranium projects.

Chris Judd and Hashan De Silva on CT scans done standing up

AFL great, turned Cerutty Macro Fund portfolio manager, Chris Judd is with HP Rx founder and managing partner Hashan De Silva for today's Talk Ya Book discussing CurveBeam AI (ASX:CVB) for today's Talk Ya Book.

Copper is the new uranium as a 2024 bull rally takes off. But can it last? – and stocks to watch

Unless you've been living under a rock through 2024, you're probably well aware that copper is currently booming.

Cleo Diagnostics reports its ovarian cancer blood tests superior to ultrasound

Nine moths after listing on the ASX, Cleo Diagnostics (ASX:COV) has made its first major biotech breakthrough.The company @ developing a blood test to detect ovarian cancer as opposed to relying on ultrasound @ has declared its blood tests detected 90% of early-stage cancers in participating pati...